Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Reporter alleles that inform on differences in Cre recombinase expressionMark Klinger, Stephen A Chmura, Nigel KilleenPlos One|September 27, 2013
Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cellsMark Klinger, Katherine Kong, Martin Moorhead, et al.Blood|September 27, 2008
MLL5 contributes to hematopoietic stem cell fitness and homeostasisYan Zhang, Jasmine Wong, Mark Klinger, et al.Science Translational Medicine|May 30, 2014
Improved survival with T cell clonotype stability after anti-CTLA-4 treatment in cancer patientsEdward Cha, Mark Klinger, Yafei Hou, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Thymic OX40 expression discriminates cells undergoing strong responses to selection ligandsMark Klinger, Joong Kyu Kim, Stephen A Chmura, et al.Plos One|October 29, 2015
Multiplex Identification of Antigen-Specific T Cell Receptors Using a Combination of Immune Assays and Immune Receptor SequencingMark Klinger, Francois Pepin, Jen Wilkins, et al.Plos One|August 12, 2009
Impact of the TCR signal on regulatory T cell homeostasis, function, and traffickingJoong Kyu Kim, Mark Klinger, Jonathan Benjamin, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytesAnne M Norment, Lisa Y Bogatzki, Mark Klinger, et al.Proceedings of the National Academy of Sciences of the United States of America|November 24, 2006
Activation of an oncogenic microRNA cistron by provirus integrationClifford L Wang, Bruce B Wang, Gábor Bartha, et al.Cancer Research|December 30, 2016
Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell RepertoireDavid Y Oh, Jason Cham, Li Zhang, et al.Pageof 3